LONDON/MUMBAI (Reuters) - India's Ranbaxy Laboratories has tentative U.S. approval to sell a generic form of AstraZeneca's blockbuster heartburn and ulcer pill Nexium, damaging confidence in the Anglo ...
TRENTON, N.J. (AP) -- Drugmakers AstraZeneca PLC and Pfizer Inc. have reached a deal giving Pfizer future rights to sell a nonprescription version of AstraZeneca's blockbuster heartburn drug, Nexium, ...
Will the FDA ever allow Ranbaxy Laboratories to sell a generic version of the Nexium heartburn pill? The Connecticut attorney general wants to know what is taking the agency so long, because Ranbaxy ...
Consider: the sixth-most prescribed Part D drug in 2013 was a close cousin of Nexium, a heartburn drug called omeprazole, given to nearly 6.4 million beneficiaries, noted Dr. Michael Steinman, a ...
The FDA approved the first generic version of Nexium — esomeprazole magnesium delayed-release capsules — to treat gastroesophageal reflux disease. Esomeprazole is a proton pump inhibitor that reduces ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results